Recommended Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Nature Communications | Phase II Study Results of Ociperlimab Combined with Tislelizumab in Advanced Esophageal Squamous Cell Carcinoma
2026-10-31
【Frontier Express】Antibodies | Conditionally Protective Role of the Complement System and Mechanisms of Therapeutic Resistance in HER2-Positive Breast Cancer
2026-10-31
【Frontier Express】Nature Communications | Phase II CLEAR-EC Trial of Cadonilimab Combined with Lenvatinib for Advanced Endometrial Cancer and the Value of Dynamic ctDNA Monitoring
2026-10-31
【Frontier Express】Antibodies | Antibody Discovery in Ankylosing Spondylitis: From Multi-Omics Integration to AI-Driven Precision Therapy Strategies
2026-10-31
【Frontier Express】Nature Cancer | New Paradigm in Immunotherapy for Small-Cell Lung Cancer: From Checkpoint Inhibitors to DLL3-Targeted Bispecific Antibodies and Biomarker Exploration
2026-10-30
【Frontier Express】Antibodies | Head-to-Head Comparison and Validation of Three Anti-FAP Antibody Clones Across Multiple Cancer Tissues
2026-10-30
【Frontier Express】Nature Communications | Extracellular Vesicle Proteins Monitor and Interfere with CLDN18.2-Targeted CAR-T and Antibody Therapies for Gastrointestinal Cancers
2026-10-30






